The ensemble of chemicals identified as activators of c-Maf-inducing protein functions through diverse mechanisms, engaging different components of cellular signaling pathways. Compounds like Forskolin and Prostaglandin E2 exert their effects by increasing intracellular cAMP levels, which is a second messenger that activates protein kinase A (PKA). The activation of PKA can then lead to the phosphorylation of transcription factors such as CREB, which in turn may enhance the transcription of genes including those related to c-MIP.
Similarly, the modulation of intracellular calcium levels through compounds like A-23187 and Ionomycin can activate signaling pathways such as those mediated by calcineurin and NFAT, which are known to participate in the regulation of a variety of genes, potentially including c-MIP. Moreover, PMA and Anisomycin act through the activation of protein kinase C (PKC) and c-Jun N-terminal kinase (JNK) pathways, respectively, both of which can influence transcription factors such as NF-κB and AP-1. These factors have broad regulatory roles in gene expression, and their modulation can impact the levels of c-MIP.
SEE ALSO...
Items 11 to 12 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
cAMP analog that resists degradation, can activate PKA and potentially enhance c-MIP expression. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
JNK activator that may influence AP-1 transcription factor, which can have downstream effects on c-MIP levels. | ||||||